Xconomy National

Archives

by in

Entry	Author	Date	Location
San Diego Life Sciences Roundup: Isis, Elevation, Proacta, and More	Bruce V. Bigelow	01/06/12	San Diego
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers	Erin Kutz	01/06/12	Boston
Isis, Biogen Strike Potential $299M Deal For Rare Spine Disorder Treatment	Luke Timmerman	01/04/12	San Diego
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug	Luke Timmerman	01/04/12	Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego	Bruce V. Bigelow	12/28/11	San Diego
Buyouts, Quantified Health, & More San Diego Life Sciences News	Bruce V. Bigelow	12/01/11	San Diego
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring	Luke Timmerman	11/22/11	San Diego
Orexigen’s Diet Drug Springs Back to Life, Independa Gets $1.6M, NuVasive Faces Big Judgments in Patent Dispute, & More San Diego Life Sciences News	Bruce V. Bigelow	09/22/11	San Diego
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company	Luke Timmerman	06/02/11	Seattle
AVI Biopharma Adds Chief Scientist	Luke Timmerman	03/28/11	Seattle
Astute Medical Nabs $13M, Roth Capital Hosts Conference, Kaldor Joins Versant, & More San Diego Life Sciences News	Bruce V. Bigelow	03/10/11	San Diego
Alder Steers Next Antibodies To Unusual Places: Treating Migraines and High Cholesterol	Luke Timmerman	03/02/11	Seattle
Illumina Rides Business Surge, IntegenX Acquires GenValult, Orexigen Cuts Payroll, & More San Diego Life Science News	Bruce V. Bigelow	02/10/11	San Diego
Regulus, the MicroRNA Child of Alnylam and Isis, Offers Litmus Test for Biotech Hope in 2011	Luke Timmerman	02/07/11	San Diego
Isis Spinoff Altair Therapeutics Shut Down, After Mid-Stage Asthma Study Fails	Luke Timmerman	02/03/11	San Diego
How Lilly Let Telaprevir Go to Vertex, SV Focusing on Health IT With Latest Fund, Genzyme Isis Cholesterol Drug Shows Strong in Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	08/06/10	Boston
Of Genzyme, Sanofi-Aventis, Biotech Buyout Gossip, and Angry Patients	Ryan McBride	08/05/10	Boston
Conatus Gets Idun, Trius Goes Public, BrainCells Gets Sabcomeline, & More San Diego-Area Life Sciences News	Bruce V. Bigelow	08/05/10	San Diego
Genzyme, Isis Cholesterol Drug Passes Pair of Clinical Trials; Shares Fall Anyway	Luke Timmerman	08/04/10	Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug	Ryan McBride	07/02/10	Boston
Regulus Therapeutics, Spinoff of Isis and Alnylam, Forms $750M MicroRNA Deal With Sanofi	Luke Timmerman	06/22/10	San Diego
Cooking with the Genzyme Recipe: New Players Funding Rare Disease Drugs in Boston	Ryan McBride	04/12/10	Boston
Isis Snags Glaxo Deal, Orexigen Heads to FDA, Cyntellect Pockets $3M & More San Diego Area Life Sciences News	Luke Timmerman	04/01/10	San Diego
Isis Nabs $35M Payment From Glaxo	Luke Timmerman	03/31/10	San Diego
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News	Denise Gellene	03/11/10	San Diego
Isis Nabs $6M Bristol Payment	Luke Timmerman	03/08/10	San Diego
Regulus, the MicroRNA Child of Isis and Alnylam, Strikes Potential $150M Deal with Glaxo	Luke Timmerman	02/25/10	San Diego
Zafgen Plans Weight-Loss Study, Infinity CEO Perkins Plans for Growth, Boston Scientific Cuts 1000+ Jobs, & More Boston-Area Life Sciences News	Rebecca Zacks	02/12/10	Boston
Halozyme Pursues Anti-Cellulite Drug, Optimer’s Antibiotic Kills C. Difficile Germs, Tragara Pharmaceuticals Raises Funds & More San Diego Life Sciences News	Denise Gellene	02/11/10	San Diego
Genzyme and Isis Report Positive Results for Cholesterol-Lowering Drug, Liver Safety Issue Lingers	Ryan McBride	02/10/10	Boston
Page 1 of 4	next page »